To several U.S. senators, it looked wasteful, even outrageous. Every year, taxpayers pay for at least $750 million worth of expensive pharmaceuticals that are simply thrown away. Companies ship many of the drugs in “Costco”-size vials, one lawmaker said, that once opened usually cannot be resealed or saved for other patients. Yet pharma gets paid
Complete Reading

SACRAMENTO, California – Conseguir agua potable le costó a Ignacio Padilla su seguro médico. Este veterano de la Segunda Guerra Mundial necesitaba pagar el préstamo de la bomba de agua instalada en su propiedad de un acre, en el condado rural de Tulare. Ahorró cuidadosamente unos cuantos miles de dólares para poder pagar la deuda,
Complete Reading

HELENA, Mont. — The 2021 Montana legislative session will be remembered as one of the state’s most consequential as a Republican-led legislature and governor’s office passed new laws restricting abortions, lowering taxes and regulating marijuana. But the debate over those and other highly publicized issues may have caused other meaningful legislation related to health care
Complete Reading

FDA Approves Jemperli (dostarlimab-gxly) for Women with Recurrent or Advanced dMMR Endometrial Cancer London UK 22 April 2021 — GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly), a programmed death receptor-1 (PD-1) blocking antibody, based on the company’s Biologics License Application. Jemperli is indicated for the treatment of adult
Complete Reading

Could a decades-old antidepressant be a secret weapon against covid? A few scientists think so, after two small studies showed that fluvoxamine, typically prescribed for obsessive-compulsive disorder, prevented serious illness in all participants who took the pills soon after developing symptoms. It’s an exciting notion: A $10, two-week course of this drug could reduce death
Complete Reading

FDA Approves Ponvory (ponesimod) for the Treatment of Adults with Relapsing Multiple Sclerosis TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved Ponvory™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing
Complete Reading

EMERYVILLE, Calif.–(BUSINESS WIRE)–Feb. 1, 2021– Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced it has received marketing authorization from the U.S. Food and Drug Administration (FDA) for a supplemental New Drug Application for Gocovri® (amantadine) extended release
Complete Reading

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CHEMMART PERINDOPRIL tablets Contains the active ingredient perindopril erbumine Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine. This leaflet answers some common questions about perindopril. It does not contain all the available information about
Complete Reading

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CYMBALTA® Duloxetine hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about CYMBALTA. It does not contain all the available information.It does not take the place of talking to your doctor or pharmacist. The information in
Complete Reading

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. Terry White Chemists Metformin 500/850/1000 Tablets Contains the active ingredient metformin (met-FOR-min) hydrochloride Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine. This leaflet answers some common questions about metformin It does not contain all
Complete Reading

Create Account



Log In Your Account